Pharma Journalist - Page 69 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

BioMarin Acquires Inozyme to Boost Enzyme Therapy Portfolio

Bristol Myers Squibb Wins EU Approval for Opdivo-Based Lung Cancer Regimen

Pfizer Signs Exclusive Licensing Deal with 3SBio

Celebrating a Decade of Innovation: The 10th Microbiome Movement Drug Development Summit

Septerna, Novo Nordisk Partner on Oral Treatments for Obesity and Cardiometabolic Diseases

FDA Accepts BioCryst’s NDA for ORLADEYO in Young HAE Patients

FDA Approves EMRELIS for Advanced NSCLC with High c-Met

Stylus Medicine Launches to Advance Precision In Vivo CAR-T Therapies

GSK to Acquire Efimosfermin for Steatotic Liver Disease

Tempus, Boehringer Ingelheim Launch Cancer Collaboration